NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amplicore Inc.

Amplicore Inc.

Private
Mason, OhioHealthcare & Life Scienceshttps://www.amplicorepharma.com/

Last Round

Series A

Jul 1, 2022

Total Funding Raised

$6M

Company Overview

Amplicore Inc. is a biopharmaceutical company that develops injectable regenerative therapeutic drugs for musculoskeletal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicineinjectable therapeuticmusculoskeletal disordermeniscal tear repairtissue regenerationbiopharmaceuticalclinical stage pharmaorthopedicsosteoarthritis treatmentdegenerative disc diseaseminimally invasive treatmentcartilage repairsports medicineInvestigational New DrugINDDoD contractor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplicore Inc. Comparables

Compare Amplicore Inc. with similar companies based on industry and business-model similarity.

Amplicore Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DiscGenics
77%
Angitia Biopharmaceuticals
76%
Spine BioPharma, Inc.
73%

Amplicore Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 1, 2022
SeedMar 25, 2021

Key People

Founding team and executive leadership

Chia-Ying Lin

Founder, President CEO

Founding Team

Amplicore Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 49% MoM.

  • Nov 11, 2025

    Monthly visitors grew 3205% MoM, from 22 to 727.

Amplicore Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amplicore Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplicore Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMason, Ohio
Employee Range7
Year Founded2018
Last FundingJul 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.